Showing 5,601 - 5,620 results of 18,568 for search '(( 50 ((we decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 5 wt decrease ))', query time: 0.76s Refine Results
  1. 5601
  2. 5602
  3. 5603
  4. 5604

    Uptake of the intervention (N = 49). by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  5. 5605

    Baseline characteristics of sample by trial arm. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  6. 5606

    CweL trial design. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  7. 5607

    Participant Flow. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  8. 5608

    Economic cost composition by arm and outcomes. by Stanley Carries (21172287)

    Published 2025
    “…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”
  9. 5609
  10. 5610

    Flow chart describing samples. by Rabi Joël Gansaonré (20416803)

    Published 2024
    “…If a child’s growth changed from severe stunting to normal growth, their risk of repeating a grade decreased by 5.0 [95% CI: 0.0; 9.0] per 100 persons-years. …”
  11. 5611
  12. 5612

    Primary data set used for analysis. by Louis Lambrechts (241741)

    Published 2023
    “…Our analysis excluded participants whose viremia was detectable at enrollment but undetectable at the time of mosquito feeding, which was the case for all participants with DENV-3 and ZIKV infections. We analyzed the probability of onward transmission during 50 feeding events involving 27 participants infected with DENV-2 based on the presence of infectious virus in mosquito saliva 7–16 days post blood meal. …”
  13. 5613

    Mutagenesis of the CXCL10 binding site on <i>L</i>. <i>(L</i>.<i>) major</i> GP63 to <i>L</i>. <i>(V</i>.<i>) panamensis</i> residues reduces CXCL10 cleavage and T cell chemotaxis. by Alejandro L. Antonia (7147739)

    Published 2021
    “…(L.) major gp63 <i>allele (D463) to the</i> L. (V.) panamensis <i>allele (N463) at the CXCL10 binding site decreases CXCR3</i><sup><i>+</i></sup> <i>T cell chemotaxis</i>. …”
  14. 5614
  15. 5615

    Raw data used for graph (related to Fig 1). by Mohammad Ali Baziyar (19353257)

    Published 2024
    “…We used MCF7 as functional estrogen and non-invasive and MDA-MB-231 cell lines as triple-negative type of breast cancer and a model for more aggressive.…”
  16. 5616
  17. 5617
  18. 5618

    Histogram of the extracted parameters. by Qiuyu Du (20760848)

    Published 2025
    “…Logistic regression (n = 93) showed that a less steep contrast gradient (decreasing by 10 Hounsfield unit/%) was associated with a reduction in odds of the following short-term adverse outcomes: 48.1% for intensive care unit admission (odds ratio [OR] = 0.519, 95% confidence interval [CI]: 0.306–0.804), 29.3% for oxygen therapy >24 hours (OR = 0.707, 95% CI: 0.496–0.976), 60.6% for reperfusion therapy (OR = 0.394, 95% CI: 0.178–0.682), 57.5% for vasopressor therapy (OR = 0.425, 95% CI: 0.194–0.741), and 50.2% for PE-related death (OR = 0.498, 95% CI: 0.246–0.915). …”
  19. 5619
  20. 5620